News | August 18, 2023
BASF, Promega and Swiss TPH collaborate to drive research for malaria control
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
Dignitaries and delegates commend India’s leadership in Global South during G20 India Presidency
lAIH strives to introduce appropriate interventions for nurturing an AMR innovation ecosystem in the country through cohesive efforts across the innovation pyramid
Two biopharmaceutical experts join SK bioscience to strengthen the future strategies
35 million mosquito nets supplied to countries in sub-Saharan Africa through partners
More women centric initiatives being the need of the hour for holistic development
The TBDA is a collaboration established among biopharmaceutical companies, research organizations and universities to accelerate the discovery and development of novel therapeutic candidates against TB.
Phase 2 study evaluating an investigational weekly oral combination treatment regimen of islatravir and Gilead Sciences’ lenacapavir to resume with lower dose of islatravir
Celanese to conduct research, prototype development and characterization of a refillable contraceptive technology with award from the Bill & Melinda Gates Foundation
Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.
Subscribe To Our Newsletter & Stay Updated
